title: Reduction of Salmonella Enteritidis in the spleens of hens by bacterins that vary in fimbrial protein SefD.
abstract: The objective of this research was to determine whether variation in the presence of fimbrial protein SefD would impact efficacy of bacterins as measured by recovery of Salmonella enterica serovar Enteritidis (Salmonella Enteritidis) from the spleens of hens. Two bacterins were prepared that varied in SefD content. Also, two adjuvants were tested, namely, water-in-oil and aluminum hydroxide gel (alum). Control groups for both adjuvant preparations included infected nonvaccinated hens and uninfected nonvaccinated hens. At 21 days postinfection, Salmonella Enteritidis was recovered from 69.7%, 53.1%, and 86.0% from the spleens of all hens vaccinated with bacterins lacking SefD, bacterins that included SefD, and infected nonvaccinated control hens, respectively. No Salmonella was recovered from uninfected nonvaccinates. Results from individual trials showed that both bacterins reduced positive spleens, but that the one with SefD was more efficacious. Alum adjuvant had fewer side effects on hens and egg production as compared to water-in-oil. However, adjuvant did not change the relative recovery of Salmonella Enteritidis from spleens. These results suggest that SefD is a promising target antigen for improving the efficacy of immunotherapy in hens, and is intended to reduce Salmonella Enteritidis in the food supply.
authors.affiliation: 1 CEVA Biomune , Lenexa, Kansas.
authors.forename: Roxana
authors.initials: R
authors.lastname: Sanchez-Ingunza
authors.affiliation: 2 U.S. Department of Agriculture, Agricultural Research Service, Athens, Georgia .
authors.forename: Jean
authors.initials: J
authors.lastname: Guard
authors.affiliation: 2 U.S. Department of Agriculture, Agricultural Research Service, Athens, Georgia .
authors.forename: Cesar A
authors.initials: CA
authors.lastname: Morales
authors.affiliation: 3 Grafton Scientific Staffing Companies , Leawood, Kansas.
authors.forename: Alan H
authors.initials: AH
authors.lastname: Icard
mesh_terms: D000818:Animals; D001428:Bacterial Vaccines / Q000737:chemistry* / Q000627:therapeutic use; D015815:Cell Adhesion Molecules / Q000494:pharmacology*; D002645:Chickens; D005260:Female; D036781:Fimbriae Proteins / Q000494:pharmacology*; D011201:Poultry Diseases / Q000382:microbiology / Q000517:prevention & control*; D012481:Salmonella Infections, Animal / Q000188:drug therapy* / Q000382:microbiology; D012477:Salmonella enteritidis / Q000187:drug effects* / Q000302:isolation & purification; D013154:Spleen / Q000382:microbiology*
chemical_list: D001428:Bacterial Vaccines; D015815:Cell Adhesion Molecules; C404505:SefD protein, Salmonella; D036781:Fimbriae Proteins